As a university hospital, we have a strong focus on continuous development and research. We are currently recruiting patients for the following clinical trials:
- PEDRO („Patient Experience Data in Radiation Oncology“): A pilot study for collecting real-world data from the patient perspective.
- OligoCare: the OligoCare-Study is a European registry study in which patients with few metastases (oligometastases) following prostate, breast, lung or colon cancer can be included. As this is an observational study, no changes in therapy or additional interventions are required, and participation in the study does not involve any additional effort or risk for patients.
- ReCare: The ReCare-Study is a European registry study in which patients who are receiving a repeated radiation therapy due to local recurrence, new primary or secondary cancer can be included.
- EMBRACE II („Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer“)
- HNO MK-3475-689 („Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma“)
- TAXIS („Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer“)